"Our company mission—to enable our customers to make the world healthier, cleaner and safer —is perfectly aligned with the priorities in China's 5-year plan," said Marc N. Casper, president and chief executive officer of Thermo Fisher. "We share a commitment to advancing precision medicine, and we're excited about strengthening our collaboration with West China Hospital to provide technologies and expertise that will ultimately improve patient care."
“We are exploring opportunities to collaborate with renowned, industry-leading international companies to harness and capitalize on our strength in pathology,” said Li Weimin, president of West China Hospital. “With our partners at Thermo Fisher, we are working to enhance the quality of pathological research and clinical diagnosis. We are also exploring an opportunity to extend our partnership in Western China by accelerating the development of precise pathological diagnoses that will ultimately help improve people’s lives.”
Richard Stengel, U.S. undersecretary of state for public diplomacy and public affairs, said, “In recent years, we have witnessed several achievements resulting from public and private partnerships between the U.S. and China—all of which aim to improve the well-being of people in both countries. The collaboration between Thermo Fisher and West China Hospital is a perfect example of America’s efforts to strengthen ties with China in science, technology and health. The agreement reinforces the spirit and goals of the CPE.”
The two parties have agreed to collaborate closely to make West China Hospital a leading global molecular diagnosis center. The joint efforts include construction of training bases for standardized pathology quality-control and standardized pathologic diagnosticians and the development of advanced laboratories with efficient, safe and integrated business procedures.
